A hemodialysis cohort study of protocol-based anticoagulation management.

about

A hemodialysis cohort study of protocol-based anticoagulation management.

Item

http://www.wikidata.org/entity/Q36261765

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A hemodialysis cohort study of protocol-based anticoagulation management.

@ast

A hemodialysis cohort study of protocol-based anticoagulation management.

@en

type

Item

label

A hemodialysis cohort study of protocol-based anticoagulation management.

@ast

A hemodialysis cohort study of protocol-based anticoagulation management.

@en

prefLabel

A hemodialysis cohort study of protocol-based anticoagulation management.

@ast

A hemodialysis cohort study of protocol-based anticoagulation management.

@en

P1476

A hemodialysis cohort study of protocol-based anticoagulation management

@en

P2093

Binyue Chang

http://www.w3.org/2001/XMLSchema#string

Lakshmi Mallela

http://www.w3.org/2001/XMLSchema#string

Tinzar Basein

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients.

The increasing prevalence of atrial fibrillation among hemodialysis patients.

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

A method to determine the optimal intensity of oral anticoagulant therapy.

P2888

s13104-017-2381-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13104-017-2381-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Lamontagne

P577

2017-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1074211166

http://www.w3.org/2001/XMLSchema#string

P698

28126020

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5270310

http://www.w3.org/2001/XMLSchema#string